• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄韧带肥厚的细胞和分子机制。

Cellular and Molecular Mechanisms of Hypertrophy of Ligamentum Flavum.

机构信息

Ferguson Laboratory for Spine Research, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA.

出版信息

Biomolecules. 2024 Oct 10;14(10):1277. doi: 10.3390/biom14101277.

DOI:10.3390/biom14101277
PMID:39456209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506588/
Abstract

Hypertrophy of the ligamentum flavum (HLF) is a common contributor to lumbar spinal stenosis (LSS). Fibrosis is a core pathological factor of HLF resulting in degenerative LSS and associated low back pain. Although progress has been made in HLF research, the specific molecular mechanisms that promote HLF remain to be defined. The molecular factors involved in the onset of HLF include increases in inflammatory cytokines such as transforming growth factor (TGF)-β, matrix metalloproteinases, and pro-fibrotic growth factors. In this review, we discuss the current understanding of the mechanisms involved in HLF with a particular emphasis on aging and mechanical stress. We also discuss in detail how several pathomechanisms such as fibrosis, proliferation and apoptosis, macrophage infiltration, and autophagy, in addition to several molecular pathways involving TGF-β1, mitogen-activated protein kinase (MAPKs), and nuclear factor-κB (NF-κB) signaling, PI3K/AKT signaling, Wnt signaling, micro-RNAs, extracellular matrix proteins, reactive oxygen species (ROS), etc. are involved in fibrosis leading to HLF. We also present a summary of the current advancements in preclinical animal models for HLF research. In addition, we update the current and potential therapeutic targets/agents against HLF. An improved understanding of the molecular processes behind HLF and a novel animal model are key to developing effective LSS prevention and treatment strategies.

摘要

黄韧带肥厚(HLF)是腰椎管狭窄症(LSS)的常见病因。纤维化是 HLF 的核心病理因素,导致退行性 LSS 和相关的下腰痛。尽管 HLF 研究取得了进展,但促进 HLF 的具体分子机制仍有待确定。HLF 发病涉及的分子因素包括转化生长因子(TGF)-β、基质金属蛋白酶和促纤维化生长因子等炎症细胞因子的增加。在这篇综述中,我们讨论了目前对 HLF 相关机制的理解,特别强调了衰老和机械应激的作用。我们还详细讨论了纤维化、增殖和凋亡、巨噬细胞浸润和自噬等几种病理机制,以及涉及 TGF-β1、丝裂原活化蛋白激酶(MAPKs)和核因子-κB(NF-κB)信号、PI3K/AKT 信号、Wnt 信号、微小 RNA、细胞外基质蛋白、活性氧(ROS)等多种分子途径如何参与导致 HLF 的纤维化。我们还总结了目前用于 HLF 研究的临床前动物模型的进展。此外,我们更新了针对 HLF 的当前和潜在治疗靶点/药物。深入了解 HLF 背后的分子过程和新型动物模型是开发有效 LSS 预防和治疗策略的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ad/11506588/7e2471df9712/biomolecules-14-01277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ad/11506588/2a7ff1bdbcb2/biomolecules-14-01277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ad/11506588/7e2471df9712/biomolecules-14-01277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ad/11506588/2a7ff1bdbcb2/biomolecules-14-01277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9ad/11506588/7e2471df9712/biomolecules-14-01277-g002.jpg

相似文献

1
Cellular and Molecular Mechanisms of Hypertrophy of Ligamentum Flavum.黄韧带肥厚的细胞和分子机制。
Biomolecules. 2024 Oct 10;14(10):1277. doi: 10.3390/biom14101277.
2
Biomarkers related to hypertrophy of the ligamentum flavum: a systematic review of the literature.与黄韧带肥厚相关的生物标志物:文献系统综述。
J Neurosurg Spine. 2024 Apr 12;41(1):33-45. doi: 10.3171/2024.2.SPINE23991. Print 2024 Jul 1.
3
TCF7/SNAI2/miR-4306 feedback loop promotes hypertrophy of ligamentum flavum.TCF7/SNAI2/miR-4306 反馈环促进黄韧带肥大。
J Transl Med. 2022 Oct 12;20(1):468. doi: 10.1186/s12967-022-03677-0.
4
Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions.黄韧带纤维化和肥厚:分子途径、细胞机制及未来方向。
FASEB J. 2020 Aug;34(8):9854-9868. doi: 10.1096/fj.202000635R. Epub 2020 Jul 1.
5
Relationship between Severity of Lumbar Spinal Stenosis and Ligamentum Flavum Hypertrophy and Serum Inflammatory Factors.腰椎管狭窄症严重程度与黄韧带肥厚及血清炎症因子的关系。
Comput Math Methods Med. 2022 Oct 12;2022:8799240. doi: 10.1155/2022/8799240. eCollection 2022.
6
Locally Produced IGF-1 Promotes Hypertrophy of the Ligamentum Flavum via the mTORC1 Signaling Pathway.局部产生的胰岛素样生长因子-1通过mTORC1信号通路促进黄韧带肥大。
Cell Physiol Biochem. 2018;48(1):293-303. doi: 10.1159/000491729. Epub 2018 Jul 17.
7
CRLF1 Is a Key Regulator in the Ligamentum Flavum Hypertrophy.CRLF1是黄韧带肥厚的关键调节因子。
Front Cell Dev Biol. 2020 Sep 18;8:858. doi: 10.3389/fcell.2020.00858. eCollection 2020.
8
Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy.全基因组 DNA 甲基化和单核苷酸多态性的综合分析鉴定 ACSM5 为腰椎黄韧带肥厚的抑制因子。
Arthritis Res Ther. 2021 Sep 30;23(1):251. doi: 10.1186/s13075-021-02625-5.
9
Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation.腰椎管狭窄症和椎间盘突出症患者黄韧带中转化生长因子-β1的定量分析
Spine (Phila Pa 1976). 2001 Nov 1;26(21):E492-5. doi: 10.1097/00007632-200111010-00007.
10
Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids.黄韧带肥厚与腰椎管狭窄症中特定脂质的异常积聚有关。
Sci Rep. 2021 Dec 6;11(1):23515. doi: 10.1038/s41598-021-02818-7.

引用本文的文献

1
Single-cell RNA-seq uncovers lineage-specific regulatory alterations of fibroblasts and endothelial cells in ligamentum flavum hypertrophy.单细胞RNA测序揭示了黄韧带肥厚中成纤维细胞和内皮细胞的谱系特异性调控改变。
Front Immunol. 2025 May 15;16:1569296. doi: 10.3389/fimmu.2025.1569296. eCollection 2025.
2
Changes in the Concentration Profile of Selected Micro- and Macro-Elements in the Yellow Ligament Obtained from Patients with Degenerative Stenosis of the Lumbo-Sacral Spine.从腰骶部脊柱退行性狭窄患者获取的黄韧带中选定的微量和常量元素浓度分布的变化。
J Clin Med. 2025 Feb 14;14(4):1252. doi: 10.3390/jcm14041252.

本文引用的文献

1
Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis.IL-6、TNF 和 IL-1β 水平与年龄相关疾病:系统评价和荟萃分析。
Front Immunol. 2024 Mar 1;15:1330386. doi: 10.3389/fimmu.2024.1330386. eCollection 2024.
2
Thrombospondin-1 promotes mechanical stress-mediated ligamentum flavum hypertrophy through the TGFβ1/Smad3 signaling pathway.血小板反应蛋白-1 通过 TGFβ1/Smad3 信号通路促进机械应力介导的黄韧带肥厚。
Matrix Biol. 2024 Mar;127:8-22. doi: 10.1016/j.matbio.2024.01.005. Epub 2024 Jan 26.
3
M1 macrophage-derived oncostatin M induces osteogenic differentiation of ligamentum flavum cells through the JAK2/STAT3 pathway.
M1巨噬细胞衍生的抑瘤素M通过JAK2/STAT3途径诱导黄韧带细胞成骨分化。
JOR Spine. 2023 Oct 18;7(1):e1290. doi: 10.1002/jsp2.1290. eCollection 2024 Mar.
4
Rapamycin mitigates inflammation-mediated disc matrix homeostatic imbalance by inhibiting mTORC1 and inducing autophagy through Akt activation.雷帕霉素通过抑制mTORC1并通过激活Akt诱导自噬来减轻炎症介导的椎间盘基质稳态失衡。
JOR Spine. 2024 Jan 2;7(1):e1303. doi: 10.1002/jsp2.1303. eCollection 2024 Mar.
5
ROS production by mitochondria: function or dysfunction?线粒体产生 ROS:功能还是障碍?
Oncogene. 2024 Jan;43(5):295-303. doi: 10.1038/s41388-023-02907-z. Epub 2023 Dec 11.
6
ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway.ACSM5 通过调节 FABP4/PPAR 信号通路介导的脂质积累抑制黄韧带肥厚。
Biol Direct. 2023 Nov 14;18(1):75. doi: 10.1186/s13062-023-00436-z.
7
Transforming Growth Factor-β Induces Interleukin-6 Secretion from Human Ligamentum Flavum-Derived Cells through Partial Activation of p38 and p44/42 Mitogen-Activated Protein Kinases.转化生长因子-β通过部分激活p38和p44/42丝裂原活化蛋白激酶诱导人黄韧带来源细胞分泌白细胞介素-6。
Asian Spine J. 2023 Dec;17(6):997-1003. doi: 10.31616/asj.2023.0025. Epub 2023 Nov 10.
8
Macrophage polarization in tissue fibrosis.组织纤维化中的巨噬细胞极化。
PeerJ. 2023 Oct 13;11:e16092. doi: 10.7717/peerj.16092. eCollection 2023.
9
TGF-β signaling in health and disease.转化生长因子-β 信号在健康和疾病中的作用。
Cell. 2023 Sep 14;186(19):4007-4037. doi: 10.1016/j.cell.2023.07.036.
10
Intervertebral disc degeneration and inflammatory microenvironment: expression, pathology, and therapeutic strategies.椎间盘退变与炎症微环境:表达、病理及治疗策略
Inflamm Res. 2023 Sep;72(9):1811-1828. doi: 10.1007/s00011-023-01784-2. Epub 2023 Sep 4.